Cargando…
D24. Beyond Cost-effectiveness of Treatment for Dupuytren Disease: What is the Financial Impact on Healthcare Providers?
Autores principales: | Kuo, Shih-Chiang Edward, Ngaage, Ledibabari Mildred, Shores, Jaimie T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10125660/ http://dx.doi.org/10.1097/01.GOX.0000934708.12206.7f |
Ejemplares similares
-
31. How Many Plastic Surgeons Does it Take to Write A Paper? A 10-year Bibliometric Analysis of Authorship Inflation
por: Ngaage, Ledibabari M., et al.
Publicado: (2023) -
D3. Time from Collagenase Injection to Manipulation Does Not Affect Outcomes in Dupuytren’s Disease
por: Bingham, Elijah G., et al.
Publicado: (2023) -
119. Ultrasound Evaluation for Findings of Acute Carpal Tunnel Syndrome after Distal Radius Fracture
por: Ngaage, Ledibabari M., et al.
Publicado: (2023) -
19. The Financial Impact of a Co-surgeon in Breast Microsurgery
por: DeVito, Robert G., et al.
Publicado: (2023) -
D145. A Novel “Smooth” Breast Implant Surface Design That Provides Implant Stability
por: Salazar, Hector F., et al.
Publicado: (2023)